GlassScriptPhysician profile
Barbara Jane Singer
NPI 1417092586
$1,988.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $182 · 2021: $472 · 2022: $564 · 2023: $337 · 2024: $70.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $598.22 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $414.35 | 2019-2023 | Evenity, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $164.80 | 2021-2024 | Trintellix |
| Bausch Health US, LLC | $136.91 | 2021-2023 | Aplenzin, Wellbutrin |
| Currax Pharmaceuticals LLC | $118.87 | 2021-2024 | Contrave, Onzetra Xsail, Nexlizet |
| Sanofi-Aventis U.S. LLC | $114.61 | 2019-2021 | |
| Qol Medical, LLC | $103.86 | 2021-2022 | |
| Abbvie INC. | $95.52 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $46.31 | 2022 | |
| Shire North American Group INC | $40.17 | 2019 | |
| Acella Pharmaceuticals, LLC | $31.53 | 2021-2023 | NP Thyroid 60 |
| Jazz Pharmaceuticals INC. | $30.82 | 2020-2022 | |
| Exact Sciences Corporation | $20.85 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.48 | 2020 | |
| Tris Pharma INC | $17.99 | 2023 | Dyanavel Xr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $17.13 | 2019 | |
| Glaxosmithkline, LLC. | $16.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.